AKT1 and hepatocellular carcinoma: Preventing liver tumorigenesis and reducing the HCC incidence; Ameliorating liver damage and decreasing tumor markers; Reducing the oxidative stress markers; Inhibiting inflammation in hepatocarcinogenesis process though NF-κB signaling pathway; Inducing apoptosis and inhibiting proliferation though PI3K/Akt pathway